NVP Associates
Latest statistics and disclosures from NVP Associates's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Mbx Biosciences, Zenas Biopharma, TALK, DAVE, UDMY, and represent 92.99% of NVP Associates's stock portfolio.
- Added to shares of these 2 stocks: Mbx Biosciences (+$56M), Zenas Biopharma (+$31M).
- Started 2 new stock positions in Zenas Biopharma, Mbx Biosciences.
- NVP Associates was a net buyer of stock by $87M.
- NVP Associates has $176M in assets under management (AUM), dropping by 92.99%.
- Central Index Key (CIK): 0001545692
Tip: Access up to 7 years of quarterly data
Positions held by NVP Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for NVP Associates
NVP Associates holds 8 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Mbx Biosciences | 31.5 | $56M | NEW | 2.1M | 25.98 |
|
| Zenas Biopharma | 17.7 | $31M | NEW | 1.8M | 16.92 |
|
| Talkspace (TALK) | 17.4 | $31M | 15M | 2.09 |
|
|
| Dave Class A Com New (DAVE) | 13.2 | $23M | 583k | 39.96 |
|
|
| Udemy (UDMY) | 13.2 | $23M | 3.1M | 7.44 |
|
|
| Opendoor Technologies (OPEN) | 4.8 | $8.4M | 4.2M | 2.00 |
|
|
| Grove Collaborative Hold Com Cl A (GROV) | 2.3 | $4.0M | 2.9M | 1.35 |
|
|
| Digital Brands Group Com New (DBGI) | 0.0 | $214.014000 | 636.00 | 0.34 |
|
Past Filings by NVP Associates
SEC 13F filings are viewable for NVP Associates going back to 2022
- NVP Associates 2024 Q3 filed Nov. 12, 2024
- NVP Associates 2024 Q2 filed Aug. 13, 2024
- NVP Associates 2024 Q1 filed May 10, 2024
- NVP Associates 2023 Q4 filed Feb. 14, 2024
- NVP Associates 2023 Q3 filed Nov. 8, 2023
- NVP Associates 2023 Q2 filed Aug. 1, 2023
- NVP Associates 2023 Q1 filed May 15, 2023
- NVP Associates 2022 Q4 filed Feb. 14, 2023